Gluten exposure
Typical setting: Wheat, barley and rye ingestion.
Resistant gliadin-related peptides reach the small bowel and provide the antigenic driver; oats require contamination-aware specialist advice.
Coeliac disease module
Understand coeliac disease as HLA-associated immune injury triggered by gluten, causing small-intestinal villous atrophy, malabsorption and intestinal and extra-intestinal manifestations.
Clinically reviewed by Mark · NMC-registered nurse
Aetiology
Gluten is necessary, but HLA susceptibility and immune context determine disease.
Typical setting: Wheat, barley and rye ingestion.
Resistant gliadin-related peptides reach the small bowel and provide the antigenic driver; oats require contamination-aware specialist advice.
Typical setting: Almost all affected people carry a permissive HLA molecule.
These molecules bind deamidated gluten peptides for T-cell presentation, but carriage is common and not sufficient for disease.
Typical setting: First-degree relatives, type 1 diabetes or autoimmune thyroid disease.
Shared HLA and immune-regulatory genetics increase prevalence and justify a lower threshold for testing.
Typical setting: More common in coeliac disease than the general population.
It reflects shared immune susceptibility and makes standard IgA serology falsely negative unless total IgA is checked.
Typical setting: Infections and microbiome or feeding factors have been studied.
They may alter mucosal permeability and tolerance, but no single infection or feeding practice is a sufficient proven cause.
Mechanism chain
Gluten peptides are modified, presented and converted into T-cell and epithelial injury.
Proline-rich gliadin fragments persist in the lumen and cross the epithelial barrier.
Enzymatic modification gives peptides higher affinity for HLA-DQ2 or DQ8.
Keep exploring